98 results on '"Zhang, Chen-Ping"'
Search Results
2. Supplementary Figure 2 from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease
3. Supplementary Figure 4 from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease
4. Supplementary Figure 2 from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease
5. Supplementary Figure 4 from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease
6. Data from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease
7. Supplementary Tables 1 - 5 from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease
8. Data from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease
9. Supplementary Figure 1 from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease
10. Supplementary Figure 3 from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease
11. Supplementary Tables 1 - 5 from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease
12. Supplementary Figure 1 from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease
13. Assessment of neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil in patients with oral cavity cancer
14. Tracking the dropout patients of neoadjuvant chemotherapy with locally advanced oral cavity cancer
15. Phase III trial of docetaxel cisplatin 5‐fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome
16. Diffuse-type tenosynovial giant cell tumor of the temporomandibular joint with skull base invasion: a report of 22 cases with literature review
17. A Novel Laryngoscope-assisted Method for Sealing Pharyngocutaneous Fistula
18. Normal BMI predicts the survival benefits of inductive docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced oral squamous cell carcinoma
19. Cyclin D1 overexpression enhances chemosensitivity to TPF chemotherapeutic agents via the caspase‑3 pathway in oral cancer
20. Assessing the magnetic resonance imaging in determining the depth of invasion of tongue cancer
21. High‐risk lymph node ratio predicts worse prognosis in patients with locally advanced oral cancer
22. The Oral Microbiota May Have Influence on Oral Cancer
23. The neural system regulates bone homeostasis via mesenchymal stem cells: a translational approach
24. Anatomic extent of lymph node metastases as an independent prognosticator in node-positive major salivary gland carcinoma: A study of the US SEER database and a Chinese multicenter cohort
25. Clinical Application of Temporary External Fixator for Immediate Mandibular Reconstruction
26. Improved accuracy of hemimandibular reconstructions involving the condyle by utilizing hydroformed reconstruction plates rather than hand‐bent stock plates
27. Salivary gland carcinoma in Shanghai (2003–2012): an epidemiological study of incidence, site and pathology
28. Randomized control trial comparing the titanium osteosynthesis and the biodegradable osteosynthesis in mandibulotomy access
29. PDGFRA mRNA overexpression is associated with regional metastasis and reduced survival in oral squamous cell carcinoma
30. Oral cancer incidence in Shanghai ---- a temporal trend analysis from 2003 to 2012
31. Identification of SCARA5 as a Potential Biomarker for Oral Squamous Cell Carcinoma using MALDI-TOF-MS Analysis
32. Modified maxillary reconstruction technique for Brown's class III defects by subdividing a rhomboid shaped iliac crest into 2 subunits
33. Elevated growth differentiating factor 15 expression predicts long‑term benefit of docetaxel, cisplatin and 5‑fluorouracil induction chemotherapy in patients with oral cancer
34. Proper Choice of Donor Site Veins for Patients Undergoing Free Radial Forearm Flap Reconstruction for the Defects of Head and Neck
35. Management strategy in patient with familial gigantiform cementoma
36. Justification of routine venous thromboembolism prophylaxis in head and neck cancer reconstructive surgery
37. Low Pretreatment Lymphocyte-Monocyte Ratio and High Platelet-Lymphocyte Ratio Indicate Poor Cancer Outcome in Early Tongue Cancer
38. Preventing Early-Stage Graft Bone Resorption by Simultaneous Innervation: Innervated Iliac Bone Flap for Mandibular Reconstruction
39. PDGFRA mRNA is overexpressed in oral cancer patients as compared to normal subjects with a significant trend of overexpression among tobacco users
40. Clinical Application of an Original Vascular Anastomosis: A Clinical Multicenter Study
41. CD73 is associated with poor prognosis in HNSCC
42. CD73 as a novel marker for poor prognosis of oral squamous cell carcinoma
43. Oropharyngeal reconstruction with a pedicled submandibular gland flap
44. Expression of SOX2 in oral squamous cell carcinoma and the association with lymph node metastasis
45. A modified technique for reconstruction of a total maxillary defect
46. Post-operative hemimaxillectomy rehabilitation using prostheses supported by zygoma implants and remaining natural teeth
47. XL413, a cell division cycle 7 kinase inhibitor enhanced the anti-fibrotic effect of pirfenidone on TGF-β1-stimulated C3H10T1/2 cells via Smad2/4
48. Elective versus therapeutic neck dissection in node-negative oral cancer: Evidence from five randomized controlled trials
49. Mutant GDF15 presents a poor prognostic outcome for patients with oral squamous cell carcinoma
50. The Harmonic Scalpel versus Conventional Hemostasis for Neck Dissection: A Meta-Analysis of the Randomized Controlled Trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.